Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2801
-0.0217 (-7.19%)
Oct 30, 2026, 11:53 AM EDT - Market open
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $44.73 million as of October 30, 2026. Its market cap has decreased by 85.36% in one year.
Market Cap
44.73M
Enterprise Value
15.64M
1-Year Change
-85.36%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $44.73M, a decrease of -64.17%. That is a compound annual growth rate of -12.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 44.73M | -32.55% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 50.54M |
| Caribou Biosciences | 49.39M |
| iBio, Inc. | 49.32M |
| Elicio Therapeutics | 48.10M |
| Biomea Fusion | 46.56M |
| Hyperion DeFi | 46.46M |
| LeonaBio | 46.07M |
| ImageneBio | 45.63M |